Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Hemangioma, Capillary 2Weight Loss 1Spinal Cord Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Hemangioma 1Cachexia 1

Interventions

Radiosurgery 4Surveys and Questionnaires 3Radiotherapy 3Magnetic Resonance Imaging 3Magnetic Resonance Spectroscopy 2Carboplatin 2tozuleristide 1pembrolizumab 1etoposide phosphate 1Vincristine 1Therapeutics 1Standard of Care 1Sodium Chloride 1Saline Solution 1Restraint, Physical 1Propranolol 1Pregabalin 1Patient Discharge 1Neurofibromin 1 1Minocycline 1Microarray Analysis 1Melphalan 1Megestrol Acetate 1Infusions, Intra-Arterial 1Immunohistochemistry 1Ifosfamide 1Hospitalization 1Genetic Testing 1Fluorodeoxyglucose F18 1Fluoridation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Spinal Cord Neoplasms × Atenolol × Clear all
NCT05106179 2021-11-03

The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma

Center for Vascular Pathology, Moscow

Phase 4 Unknown
1,000 enrolled
CNS

Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡